Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Susan, Nahirniak"'
Autor:
Adam Greene, Jan Trojanowski, Andrew W. Shih, Rob Evans, Eddie Chang, Susan Nahirniak, Dallas Pearson, Oksana Prokopchuk-Gauk, Doug Martin, Charles Musuka, Cindy Seidl, Michael Peddle, Yulia Lin, Justin A. Smith, Scott MacDonald, Lindsay Richards, Michael Farrell, Brodie Nolan
Publikováno v:
Resuscitation Plus, Vol 13, Iss , Pp 100357- (2023)
Objective: Out-of-hospital blood transfusion (OHBT) is becoming increasingly common across the prehospital environment, yet there is significant variability in OHBT practices. The Canadian Prehospital and Transport Transfusion (CAN-PATT) network was
Externí odkaz:
https://doaj.org/article/a3b8d17729b541bb993d5cc9cd726a57
Cost-Effectiveness of Thrombopoietin Mimetics in Patients with Thrombocytopenia: A Systematic Review
Autor:
Hans Van Remoortel, Hans Scheers, Bert Avau, Jørgen Georgsen, Susan Nahirniak, Nadine Shehata, Simon J. Stanworth, Emmy De Buck, Veerle Compernolle, Philippe Vandekerckhove
OBJECTIVES: Thrombopoietin (TPO) mimetics are a potential alternative to platelet transfusion to minimize blood loss in patients with thrombocytopenia. This systematic review aimed to evaluate the cost-effectiveness of TPO mimetics, compared with not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e59697e296686f8353e516940299b56
https://lirias.kuleuven.be/handle/20.500.12942/720100
https://lirias.kuleuven.be/handle/20.500.12942/720100
Autor:
Andres Garcia Guerra, Lindsay Ryerson, Daniel Garros, Susan Nahirniak, Don Granoski, Olivia Calisin, Cathy Sheppard, Laurance Lequier, Gonzalo Garcia Guerra
Publikováno v:
ASAIO Journal.
Autor:
Linda Bodecker Zingmark, Nancy M. Dunbar, Agneta Wikman, Karla Maldonado Silva, Iñigo Romon, Amalia Bravo, Norbert Lubenow, Erica M. Wood, Ana Paula Hitomi Yokoyama, Vernon J. Louw, Philip Crispin, Perry Loebenberg, Lilian Castilho, Jose Mauro Kutner, Nita Radhakrishnan, Pedro Sanroma, Briony Shaw, Alyssa Ziman, Seema Dua, Dora Garcia, Emmanuel Fernandez Sanchez, Zoe McQuilten, Tara Redfern, Satyam Arora, Jeannie Callum, Susan Nahirniak, Davinder Sidhu
Publikováno v:
Vox Sanguinis. 117:616-623
Publikováno v:
Transfusion
Autor:
Bert Avau, Dorien O, Koen Veys, Jørgen Georgsen, Susan Nahirniak, Nadine Shehata, Simon J. Stanworth, Hans Van Remoortel, Emmy De Buck, Veerle Compernolle, Philippe Vandekerckhove
Publikováno v:
VOX SANGUINIS
BACKGROUND AND OBJECTIVES: Platelet transfusions are used across multiple patient populations to prevent and correct bleeding. This scoping review aimed to map the currently available systematic reviews (SRs) and evidence-based guidelines in the fiel
Autor:
Christina Lee, Ryan Lett, Heather Panchuk, Theodora Ruijs, Troy Thompson, Heather Blain, Dena Arnott, Oksana Prokopchuk-Gauk, Kathryn E. Webert, Chantal Armali, Fengju Xun, Sheila R Harding, Tracy Kichinko, Hertha Hughes, Shauna Dowsley, Kathy Chorneyko, Zohreh Afshar-Ghotli, Christine Cserti-Gazdewich, Nicole Pilutti, Jacob Pendergrast, Yulia Lin, Allison Collins, Jeannie Callum, Danielle Watson, Susan Nahirniak, Brent Mendez, Michael Angers, Amie Kron, Tracy Cupido, Lani Lieberman, Michelle P. Zeller
Publikováno v:
Transfusion. 61:410-422
BACKGROUND Transfusion of red blood cells (RBC) is a common procedure, which when prescribed inappropriately can result in adverse patient outcomes. This study sought to determine the impact of a multi-faceted intervention on unnecessary RBC transfus
Autor:
Catherine Burton, Jutta K. Preiksaitis, Sheila F. O'Brien, Curtis Mabilangan, Susan Nahirniak
Publikováno v:
American Journal of Transplantation. 20:3509-3519
Solid organ transplant (SOT) recipients who are cytomegalovirus (CMV) seronegative (R-) and receive seronegative donor (D-) organs have a small but currently unquantified risk of both transfusion-transmitted CMV (TT-CMV) and community-acquired CMV (C
Autor:
Jennifer Conway, Simon Urschel, Anne Halpin, Daniel Kim, Patricia Campbell, Lori J. West, Susan Nahirniak, Tara Pidorochynski, Holger Buchholz
Publikováno v:
Transplantation. 103:2715-2724
Background Ventricular assist device (VAD) therapy has become an important tool for end-stage heart failure. VAD therapy has increased survival but is associated with complications including the development of human leukocyte antigen (HLA) antibodies
Autor:
Erica M. Wood, Perry Loebenberg, Pedro Sanroma, Lilian Castilho, Jose Mauro Kutner, Vernon J. Louw, Tara Redfern, Karla Maldonado Silva, Alyssa Ziman, Dora Garcia, Satyam Arora, Emmanuel Fernandez Sanchez, Nita Radhakrishnan, Linda Bodecker Zingmark, Seema Dua, Zoe McQuilten, Briony Shaw, Nancy M. Dunbar, Jeannie Callum, Ana Paula Hitomi Yokoyama, Davinder Sidhu, Amalia Bravo, Norbert Lubenow, Susan Nahirniak, Iñigo Romon, Philip Crispin, Agneta Wikman
Publikováno v:
Vox sanguinis. 117(4)